Global Blood Therapeutics Inc
(NASDAQ : GBT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.00%205.101.2%$477.70m
GILDGilead Sciences, Inc.
0.91%75.510.9%$401.46m
BIIBBiogen Inc.
1.22%345.411.3%$352.23m
CELGCelgene Corporation
-0.66%87.721.2%$341.18m
ILMNIllumina, Inc.
0.52%358.163.5%$248.76m
REGNRegeneron Pharmaceuticals, Inc.
0.78%390.282.6%$232.51m
VRTXVertex Pharmaceuticals Incorporated
-0.24%180.081.9%$168.98m
EXASExact Sciences Corporation
1.72%76.2825.3%$162.68m
SRPTSarepta Therapeutics, Inc.
-3.43%147.5916.4%$129.44m
AAgilent Technologies, Inc.
-0.58%70.721.5%$124.93m
VKTXViking Therapeutics, Inc.
-4.06%18.200.9%$115.92m
ALXNAlexion Pharmaceuticals, Inc.
-2.10%121.992.0%$114.40m
NKTRNektar Therapeutics
0.96%59.005.6%$106.74m
BMRNBioMarin Pharmaceutical Inc.
-2.55%97.844.4%$97.41m
ALNYAlnylam Pharmaceuticals, Inc
-0.67%94.579.7%$93.14m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.